KOMORBID KASALLIKLAR BILAN BOG‘LIQ PSORIAZ KASALLIGIGA CHALINGAN BEMORLARNI DIAGNOSTIKA VA DAVOLASH USULLARINI TAKOMILLASHTIRISH
Keywords:
POL (peroksid oksidlanish jarayonlari ) Psoriaz, komorbid kasalliklar, metabolik sindrom, psoriatik artrit, diagnostika, kompleks davolash.Abstract
Bugungi kungacha psoriaz kasalligi va uning komorbid (birga uchraydigan) kasalliklari bilan bog‘liq diagnostika va davolash usullarini takomillashtirish bo‘yicha dunyo miqyosida olib borilgan ilmiy izlanishlar minglab ilmiy maqolalar, tahliliy tadqiqotlar va klinik izlanishlarni o‘z ichiga oladi, ya’ni bu soha juda keng tadqiq etilgan.
Downloads
References
1. Bagel I., Nelson E., Keegan B.R. Apremilast and narrowband ultraviolet-B combination therapy. for treating moderate-to-severe.plaque.psoriasis. JDrugs Dermatol. 2017; 16 (10): 957-962.
2. Carrascosa_J.M., van Doorn M.B., Lahfa M. et al. Clinical relevance of immunogenicity of biologics in psoriasis: implications for treatment strategies. I Eur Acad Dermatol Venereol.2014; 28 (11): 1424-14
3. .Menter A., Tyring S.K., Gordon K. et al. Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial. JAm Acad Dermatol. 2008; 58: 106-119
4. Gordon K.B., Langley_R.G., Leonardi C. et al. Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open: label extension study. I Am Acad Dermatol. 2006; 55 (4): 598-620
5. Gisondi P., Girolomoni G. Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis. Drug Design, Development and Therapy 2016:10; 1763
